Jason Ukman
Managing editor
STAT
Name |
The inside story of how data integrity issues roiled a biotech seen as ‘Moderna 2.0’ |
Description |
This exclusive story pulled back the curtain on a biotech seen as "Moderna 2.0." Based on months of reporting, it revealed that data integrity issues had roiled the company, forcing it to shelve its most advanced programs and causing it to miss its internal goals for a clinical trial. None of this was previously known. But based on interviews with a dozen people with knowledge of the company’s inner workings, the authors were able to show how easy it was for Larondes to get carried away with the promise of new therapies, despite signs of trouble. Username: contest@statnews.com Password: stat123 |
URLs |
|
Categories |
|
Inscribe copy |
Allison DeAngelis, STAT, and Ryan Cross, The Boston Globe |
